Summary
This prediction ended on 27.01.22 with a price of €27.74. The BUY prediction by krebskrebs for Inpixon performed very badly with a performance of -71.11%. krebskrebs has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Inpixon | - | - | - | - |
| iShares Core DAX® | 0.985% | 8.314% | 7.032% | 49.791% |
| iShares Nasdaq 100 | 2.067% | 16.765% | 35.952% | 96.632% |
| iShares Nikkei 225® | 2.270% | 15.605% | 46.568% | 69.047% |
| iShares S&P 500 | 1.043% | 11.077% | 26.456% | 68.087% |
Comments by krebskrebs for this prediction
In the thread Inpixon diskutieren
In the thread Trading Inpixon
Die von krebskrebs gewählte maximale Laufzeit wurde überschritten